BRIGHT MINDS BIOSCIENCES INC. earnings per share and revenue

DRUG earnings per share for the last quarter are -0.17 CAD whereas the estimation was -0.60 CAD which accounts for 71.67% surprise. Estimated earnings per share for the next quarter are -0.41 CAD, and revenue is expected to reach 0.00 CAD. Also watch annual changes over time to get a bigger picture of DRUG earnings per share and revenue dynamics.